Last edition
News about Market
Dr Reddy's inks Rs 1,850-crore deal with Wockhardt; to acquire 62 brands & Baddi unit
Dr Reddy's Laboratories on Wednesday announced it would acquire Wockhardt's select divisions of branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives for consideration for Rs 1,850 crore.
Market | 03/03/2020 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members